MSBi Valorisation is a Montreal-based venture capital company founded in 2003.
MSBi Valorisation's investments included Leap Medical, Milestone Pharmaceuticals and Mimetogen Pharmaceuticals. They exited their investment in Milestone Pharmaceuticals.
MSBi Valorisation's investments included Leap Medical, Milestone Pharmaceuticals and Mimetogen PharmaceuticalsMimetogen Pharmaceuticals. They exited their investment in Milestone Pharmaceuticals.
MSBi Valorisation was a venture capital firmventure capital firm that provides capital, manpower and business experience to monetize promising technologies developed within McGill University, Université de Sherbrooke and Bishop's University and their affiliated research centers. MSBi Valorisation was in the business of creating spin-offs as well as technology opportunities ready to be licensed by existing companies. They were based in Montréal, Québec and were founded in 2003.
MSBi Valorisation was a venture capital firm that provides capital, manpower and business experience to monetize promising technologies developed within McGill UniversityMcGill University, Université de Sherbrooke and Bishop's University and their affiliated research centers. MSBi Valorisation was in the business of creating spin-offs as well as technology opportunities ready to be licensed by existing companies. They were based in Montréal, Québec and were founded in 2003.
MSBi Valorisation was a venture capital firm that provides capital, manpower and business experience to monetize promising technologies developed within McGill University, Université de Sherbrooke and Bishop's University and their affiliated research centers. MSBi Valorisation was in the business of creating spin-offs as well as technology opportunities ready to be licensed by existing companies. They were based in Montréal, Québec and were founded in 2003.
MSBi Valorisation's investments included Leap Medical, Milestone Pharmaceuticals and Mimetogen Pharmaceuticals. They exited their investment in Milestone Pharmaceuticals.